Merck KGaA (XTER:MRK)
€ 155.5 -0.2 (-0.13%) Market Cap: 67.61 Bil Enterprise Value: 75.46 Bil PE Ratio: 23.96 PB Ratio: 2.53 GF Score: 89/100

Merck KGaA Bintrafusp alfa 037 Ad-Hoc - Capital Markets Q&A Call Transcript

Jan 20, 2021 / 01:00PM GMT
Release Date Price: €142.7 (-4.13%)
Operator

Good day and welcome to the bintrafusp alfa update capital markets Q&A call. Today's conference is being recorded. At this time I would like to turn the conference over to Constantin Fest. Please go ahead sir.

Constantin Fest;Marcus Kuhnert
Merck KGaA - Head of IR;Merck KGaA - CFO & Member of Executive Board<

Dear ladies and gentlemen, a very warm welcome to this Merck Capital Markets call. My name is Constantin Fest; I am Head of Investor Relations. And today we have this call to discuss today's news.

I'm delighted to have with me here today on this call Marcus Kuhnert, our Group CFO, as well as Peter Guenter, our CEO of the Healthcare Sector, as well as Danny Bar-Zohar, our Global Head of Development, and Rehan Verjee, President of EMD Serono and Global Head of Innovative Medicine Franchises, as well as Peter Halle, Head of Research, Global R&D Healthcare, to discuss all of your questions.

Without any further pause or delay, I would like directly to hand over to Marcus for a short introduction.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot